Get notified when PRGO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPerrigo completes €305.6M sale of Dermacosmetics Business to Karo Healthcare
Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read
Key Changes
-
high
Perrigo received €305.6 million in cash at closing for its Dermacosmetics Business in Northern Europe, Netherlands and Poland, including €5.6 million in net working capital adjustments. Transaction closes strategic divestiture announced in July 2025.
Item 1.01 view on EDGAR → -
medium
Company may receive up to €27 million in additional earnout payments over three years if the divested business hits undisclosed performance targets, adding potential upside to the base purchase price.
Item 1.01 view on EDGAR → -
low
Original buyer Kairos Bidco AB (KKR-managed) assigned all rights to affiliate Karo Healthcare AB prior to closing. This structural change does not affect transaction terms or economics for Perrigo.
Item 1.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.
Partner
Trade PRGO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify